Vaccine against nicotine may help users kick the habit

05/16/2005 | Los Angeles Times (tiered subscription model)

A vaccine against nicotine being tested in Switzerland helped nearly 60% of smokers who achieved a high level of antibodies stop smoking for at least six months, according to researchers at the University of Lausanne. Four companies reportedly are studying nicotine vaccines, including Cytos Biotechnology of Zurich, whose vaccine was tested, Xenova Group of Britain and U.S. firms Nabi Biopharmaceuticals and Prommune.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA